{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:28:03Z","timestamp":1793212083169,"version":"4.5.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Galapagos Pharmaceuticals"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background and Aims<\/jats:title>\n                  <jats:p>Active inflammatory bowel disease (IBD) at conception is associated with adverse pregnancy outcomes. International guidelines address antenatal care, but contraception counseling and risk assessment are not addressed. Data on healthcare professionals\u2019 guidance for women with IBD regarding contraception are scarce. We aimed to describe contraceptive use, preferences, knowledge, and barriers among women with IBD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A 34-item questionnaire was administered to female IBD patients aged 18-45. Disease control was measured using PRO-2 and IBD-control questionnaire, and contraceptive preferences were assessed by the contraceptive features survey. Logistic regression explored associations between contraceptive use, attitudes, disease remission status, and other factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 338 women surveyed, 243 (74%) used some form of contraception. Oral birth control pills (28%) and barrier methods (18%) were most used but 20% used long-acting methods. Women with active disease were more likely to use long-acting contraception (23%) compared to those in remission (17%). Contraceptive priorities were effectiveness (78%), ease of use (75%), and minimal side effects (68%). Only 25% women had discussed reproductive issues with their IBD clinician, though 85% were comfortable to do so. Preferred sources for reproductive counseling were IBD nurses (79%), general practitioners (75%), IBD doctors (68%), and gynecologists (49%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>A quarter of women with IBD were not using any contraception, and long-acting contraceptive use was low. Women prefer effective, easy-to-use contraceptives with minimal side effects but lack knowledge on effective contraception-related issues. Better education and proactive discussions between healthcare providers and patients could improve reproductive health in women with IBD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjae181","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T19:11:09Z","timestamp":1732734669000},"source":"Crossref","is-referenced-by-count":10,"title":["Knowledge, Values, and Preferences Regarding Contraceptive Choices Among Women Living With Inflammatory Bowel Disease"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1039-6251","authenticated-orcid":false,"given":"Jimmy K","family":"Limdi","sequence":"first","affiliation":[{"name":"Northern Care Alliance NHS Foundation Trust, Division of Gastroenterology-Section of IBD , Manchester ,","place":["UK"]},{"name":"Manchester Academic Health Sciences, University of Manchester , Manchester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5837-801X","authenticated-orcid":false,"given":"Sarah","family":"Rhodes","sequence":"additional","affiliation":[{"name":"Centre for Biostatistics, Division of Population Health, Health Services Research and Primary Care, University of Manchester , Manchester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6195-9245","authenticated-orcid":false,"given":"Eleanor","family":"Liu","sequence":"additional","affiliation":[{"name":"Northern Care Alliance NHS Foundation Trust, Division of Gastroenterology-Section of IBD , Manchester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5161-1747","authenticated-orcid":false,"given":"Anish J","family":"Kuriakose Kuzhiyanjal","sequence":"additional","affiliation":[{"name":"Northern Care Alliance NHS Foundation Trust, Division of Gastroenterology-Section of IBD , Manchester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8782-0292","authenticated-orcid":false,"given":"Matthew","family":"Brookes","sequence":"additional","affiliation":[{"name":"Royal Wolverhampton Hospital NHS Foundation Trust , Wolverhampton ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Farraye","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Boston Medical Center , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Cannon","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Boston Medical Center , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Woodhams","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Boston Medical Center , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis A","family":"Farraye","sequence":"additional","affiliation":[{"name":"The Mayo Clinic, Division of Gastroenterology and Hepatology, Inflammatory Bowel Disease Center , Jacksonville, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"2025060310594618900_CIT0001","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2018","journal-title":"Lancet"},{"key":"2025060310594618900_CIT0002","first-page":"1","article-title":"Conception, pregnancy and inflammatory bowel disease\u2014current concepts for the practising clinician","author":"Liu","year":"2024","journal-title":"Indian J Gastroenterol"},{"key":"2025060310594618900_CIT0003","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/ecco-jcc\/jjaa225","article-title":"The influence of disease activity on pregnancy outcomes in women with inflammatory bowel disease: a systematic review and meta-analysis","volume":"15","author":"Kim","year":"2021","journal-title":"J Crohns Colitis"},{"key":"2025060310594618900_CIT0004","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.2105\/AJPH.2013.301416","article-title":"Shifts in intended and unintended pregnancies in the United States, 2001-2008","volume":"104","author":"Finer","year":"2014","journal-title":"Am J Public Health"},{"key":"2025060310594618900_CIT0005","doi-asserted-by":"crossref","first-page":"e1152","DOI":"10.1016\/S2214-109X(20)30315-6","article-title":"Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990-2019","volume":"8","author":"Bearak","year":"2020","journal-title":"Lancet Glob Health"},{"key":"2025060310594618900_CIT0006","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/ibd\/izz025","article-title":"Contraception, venous thromboembolism, and inflammatory bowel disease: what clinicians (and patients) should know","volume":"25","author":"Limdi","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"2025060310594618900_CIT0007","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/ecco-jcc\/jjw011","article-title":"Perception of reproductive health in women with inflammatory bowel disease","volume":"10","author":"Ellul","year":"2016","journal-title":"J Crohns Colitis"},{"key":"2025060310594618900_CIT0008","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10995-009-0546-2","article-title":"Intention to become pregnant and low birth weight and preterm birth: a systematic review","volume":"15","author":"Shah","year":"2011","journal-title":"Matern Child Health J"},{"key":"2025060310594618900_CIT0009","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/ibd\/izz037","article-title":"Inflammatory bowel disease in pregnancy clinical care pathway: a report from the American Gastroenterological Association IBD Parenthood Project Working Group","volume":"25","author":"Mahadevan","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"2025060310594618900_CIT0010","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/flgastro-2020-101459","article-title":"Standards for the provision of antenatal care for patients with inflammatory bowel disease: guidance endorsed by the British Society of Gastroenterology and the British Maternal and Fetal Medicine Society","volume":"12","author":"Selinger","year":"2021","journal-title":"Frontline Gastroenterol"},{"key":"2025060310594618900_CIT0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjac115","article-title":"European Crohn\u2019s and colitis guidelines on sexuality, fertility, pregnancy, and lactation","volume":"17","author":"Torres","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2025060310594618900_CIT0012","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/fampra\/cms035","article-title":"Family planning and inflammatory bowel disease: the patient and the practitioner","volume":"30","author":"Toomey","year":"2013","journal-title":"Fam Pract"},{"key":"2025060310594618900_CIT0013","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pec.2013.09.013","article-title":"Documentation of reproductive health counseling and contraception in women with inflammatory bowel diseases","volume":"94","author":"Gawron","year":"2014","journal-title":"Patient Educ Couns"},{"key":"2025060310594618900_CIT0014","doi-asserted-by":"crossref","first-page":"otab083","DOI":"10.1093\/crocol\/otab083","article-title":"Exploring reproductive health decision experiences and preferences of women with pediatric-onset inflammatory bowel diseases","volume":"4","author":"Picciarelli","year":"2022","journal-title":"Crohns Colitis 360"},{"key":"2025060310594618900_CIT0015","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.contraception.2013.12.016","article-title":"Contraceptive method selection by women with inflammatory bowel diseases: a cross-sectional survey","volume":"89","author":"Gawron","year":"2014","journal-title":"Contraception"},{"key":"2025060310594618900_CIT0016","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","article-title":"Effectiveness of long-acting reversible contraception","volume":"366","author":"Winner","year":"2012","journal-title":"N Engl J Med"},{"key":"2025060310594618900_CIT0017","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/j.gastro.2015.12.003","article-title":"The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy","volume":"150","author":"Nguyen","year":"2016","journal-title":"Gastroenterology"},{"key":"2025060310594618900_CIT0018","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.cgh.2016.03.018","article-title":"Preconception care reduces relapse of inflammatory bowel disease during pregnancy","volume":"14","author":"de Lima","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025060310594618900_CIT0019","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/ibd.20520","article-title":"Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis","volume":"14","author":"Lewis","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"2025060310594618900_CIT0020","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/apt.13408","article-title":"Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials","volume":"42","author":"Jairath","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"2025060310594618900_CIT0021","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/gutjnl-2013-305600","article-title":"Development and validation of a rapid, generic measure of disease control from the patient\u2019s perspective: the IBD-control questionnaire","volume":"63","author":"Bodger","year":"2014","journal-title":"Gut"},{"key":"2025060310594618900_CIT0022","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1363\/4419412","article-title":"Contraceptive features preferred by women at high risk of unintended pregnancy","volume":"44","author":"Lessard","year":"2012","journal-title":"Perspect Sex Reprod Health"},{"key":"2025060310594618900_CIT0023","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cgh.2023.07.007","article-title":"High use of estrogen-based contraceptives in young women with inflammatory bowel disease in the United States","volume":"22","author":"Brenner","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025060310594618900_CIT0024","first-page":"1","article-title":"U.S. selected practice recommendations for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"2025060310594618900_CIT0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4274\/jcrpe.galenos.2019.2019.S0003","article-title":"Contraception for adolescents","volume":"12","author":"Todd","year":"2020","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"2025060310594618900_CIT0026","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1097\/MIB.0000000000000134","article-title":"The impact of hormonal contraception on disease-related cyclical symptoms in women with inflammatory bowel diseases","volume":"20","author":"Gawron","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"2025060310594618900_CIT0027","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/apt.12294","article-title":"Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease","volume":"37","author":"Yuhara","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"2025060310594618900_CIT0028","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","article-title":"Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study","volume":"375","author":"Grainge","year":"2010","journal-title":"Lancet"},{"key":"2025060310594618900_CIT0029","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1345\/aph.1C340","article-title":"Hormonal birth control and pregnancy: a comparative analysis of thromboembolic risk","volume":"37","author":"Wilks","year":"2003","journal-title":"Ann Pharmacother"},{"key":"2025060310594618900_CIT0030","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"2025060310594618900_CIT0031","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/apt.15019","article-title":"Systematic review: the consequences of psychosocial effects of inflammatory bowel disease on patients\u2019 reproductive health","volume":"48","author":"Purewal","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2025060310594618900_CIT0032","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1155\/2015\/715354","article-title":"Does the level of reproductive knowledge specific to inflammatory bowel disease predict childlessness among women with inflammatory bowel disease","volume":"29","author":"Huang","year":"2015","journal-title":"Can J Gastroenterol Hepatol"},{"key":"2025060310594618900_CIT0033","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ibd.20082","article-title":"Voluntary childlessness is increased in women with inflammatory bowel disease","volume":"13","author":"Marri","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"2025060310594618900_CIT0034","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.dld.2023.01.149","article-title":"Inflammatory bowel disease meets fertility: a physician and patient survey","volume":"55","author":"Vieujean","year":"2023","journal-title":"Dig Liver Dis"},{"key":"2025060310594618900_CIT0035","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1097\/SLA.0000000000004078","article-title":"Global overview of response rates in patient and health care professional surveys in surgery: a systematic review","volume":"275","author":"Meyer","year":"2022","journal-title":"Ann Surg"},{"key":"2025060310594618900_CIT0036","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/MLR.0000000000001784","article-title":"A systematic review of strategies to enhance response rates and representativeness of patient experience surveys","volume":"60","author":"Anhang Price","year":"2022","journal-title":"Med Care"},{"key":"2025060310594618900_CIT0037","doi-asserted-by":"crossref","first-page":"e234929","DOI":"10.1001\/jamahealthforum.2023.4929","article-title":"Survey protocols, response rates, and representation of underserved patients: a randomized clinical trial","volume":"5","author":"Elliott","year":"2024","journal-title":"JAMA Health Forum"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/advance-article-pdf\/doi\/10.1093\/ecco-jcc\/jjae181\/60983687\/jjae181.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/19\/5\/jjae181\/60983687\/jjae181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/19\/5\/jjae181\/60983687\/jjae181.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T15:00:16Z","timestamp":1748962816000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/doi\/10.1093\/ecco-jcc\/jjae181\/7909721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,8]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjae181","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2024,11,27]]},"article-number":"jjae181"}}